DCM
IMVT icon

DAFNA Capital Management’s Immunovant IMVT Stock Holding History

DAFNA Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Hold
150,524
– – 0.85% 32
2025
Q4 		$3.83M Sell
150,524
-40,969
-21% -$914K 0.89% 28
2025
Q3 		$3.09M Hold
191,493
– – 0.76% 35
2025
Q2 		$3.06M Buy
191,493
+21,497
+13% +$325K 0.85% 30
2025
Q1 		$2.91M Buy
169,996
+62,000
+57% +$1.3M 0.82% 32
2024
Q4 		$2.68M Buy
107,996
+56,000
+108% +$1.59M 0.68% 32
2024
Q3 		$1.48M Buy
51,996
+4,080
+9% +$120K 0.35% 55
2024
Q2 		$1.26M Buy
47,916
+18,500
+63% +$526K 0.3% 57
2024
Q1 		$950K Sell
29,416
-11,326
-28% -$413K 0.22% 60
2023
Q4 		$1.72M Buy
40,742
+18,242
+81% +$671K 0.41% 46
2023
Q3 		$864K Buy
+22,500
New +$509K 0.27% 61

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return